Bone Densitometry in Children and Adolescents
Денситометрия костей у детей и подростков
2016-09-26
SCID: 54.1/8t9s9yjr
Discuss with AI
bone fragilitybone mineral densitypediatric bone densitometrypediatric osteoporosisvertebral fractures
Figures from the paper
Abstract (AI)
Concerns about bone health and potential fragility in children and adolescents have led to a high interest in bone densitometry. Pediatric patients with genetic and acquired chronic diseases, immobility, and inadequate nutrition may fail to achieve expected gains in bone size, mass, and strength, leaving them vulnerable to fracture. In older adults, bone densitometry has been shown to predict fracture risk and reflect response to therapy. The role of densitometry in the management of children at risk of bone fragility is less clear. This clinical report summarizes current knowledge about bone densitometry in the pediatric population, including indications for its use, interpretation of results, and risks and costs. The report emphasizes updated consensus statements generated at the 2013 Pediatric Position Development Conference of the International Society of Clinical Densitometry by an international panel of bone experts. Some of these recommendations are evidence-based, whereas others reflect expert opinion, because data are sparse on many topics. The statements from this and other expert panels provide general guidance to the pediatrician, but decisions about ordering and interpreting bone densitometry still require clinical judgment. The interpretation of bone densitometry results in children differs from that in older adults. The terms "osteopenia" and "osteoporosis" based on bone densitometry findings alone should not be used in younger patients; instead, bone mineral content or density that falls >2 SDs below expected is labeled "low for age." Pediatric osteoporosis is defined by the Pediatric Position Development Conference by using 1 of the following criteria: ≥1 vertebral fractures occurring in the absence of local disease or high-energy trauma (without or with densitometry measurements) or low bone density for age and a significant fracture history (defined as ≥2 long bone fractures before 10 years of age or ≥3 long bone fractures before 19 years of age). Ongoing research will help define the indications and best methods for assessing bone strength in children and the clinical factors that contribute to fracture risk. The Pediatric Endocrine Society affirms the educational value of this publication.
Key Findings
1
Bone mineral content or density more than 2 standard deviations below expected should be termed “low for age,” rather than labeled osteopenia or osteoporosis based on densitometry alone.
2
Children with chronic disease, immobility, genetic conditions, or inadequate nutrition may fail to achieve expected bone size, mass, and strength, increasing fracture vulnerability.
3
Current pediatric densitometry recommendations combine evidence-based statements with expert opinion because data remain sparse; clinical judgment is still required when ordering and interpreting studies.
4
Pediatric bone densitometry has distinct indications and interpretation requirements, and its clinical role is less established than in older adults.
5
Pediatric osteoporosis is defined by vertebral fracture without local disease or high-energy trauma, or by low bone density for age combined with a significant fracture history.
Research Object
Bone densitometry in children and adolescents at risk of bone fragility
Research Subject
Clinical indications, interpretation, diagnostic criteria, risks, costs, and clinical utility of pediatric bone densitometry for assessing bone size, mass, density, strength, and fracture risk
Publication Details
Publication Date
2016-09-26
Journal
Publisher
ISSN
Cited by
180
Access Type
Author Information
Download PDF
Subscribe to digest